Evidence map›Paper›PMID 35684680›Full record

ArticleSensors (Basel, Switzerland)2022

Nuclei-Guided Network for Breast Cancer Grading in HE-Stained Pathological Images.

Rui Yan, Fei Ren, Jintao Li, Xiaosong Rao, Zhilong Lv, Chunhou Zheng, Fa Zhang

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui YanHigh Performance Computer Research Center, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100045, China.ORCID 0000-0002-1336-1740
Fei RenHigh Performance Computer Research Center, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100045, China.
Jintao LiHigh Performance Computer Research Center, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100045, China.
Xiaosong RaoDepartment of Pathology, Boao Evergrande International Hospital, Qionghai 571435, China.
Zhilong LvHigh Performance Computer Research Center, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100045, China.
Chunhou ZhengCollege of Computer Science and Technology, Anhui University, Hefei 230093, China.
Fa ZhangHigh Performance Computer Research Center, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100045, China.ORCID 0000-0002-2081-9369

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer grading methods based on hematoxylin-eosin (HE) stained pathological images can be summarized into two categories. The first category is to directly extract the pathological image features for breast cancer grading. However, unlike the coarse-grained problem of breast cancer classification, breast cancer grading is a fine-grained classification problem, so general methods cannot achieve satisfactory results. The second category is to apply the three evaluation criteria of the Nottingham Grading System (NGS) separately, and then integrate the results of the three criteria to obtain the final grading result. However, NGS is only a semiquantitative evaluation method, and there may be far more image features related to breast cancer grading. In this paper, we proposed a Nuclei-Guided Network (NGNet) for breast invasive ductal carcinoma (IDC) grading in pathological images. The proposed nuclei-guided attention module plays the role of nucleus attention, so as to learn more nuclei-related feature representations for breast IDC grading. In addition, the proposed nuclei-guided fusion module in the fusion process of different branches can further enable the network to focus on learning nuclei-related features. Overall, under the guidance of nuclei-related features, the entire NGNet can learn more fine-grained features for breast IDC grading. The experimental results show that the performance of the proposed method is better than that of state-of-the-art method. In addition, we released a well-labeled dataset with 3644 pathological images for breast IDC grading. This dataset is currently the largest publicly available breast IDC grading dataset and can serve as a benchmark to facilitate a broader study of breast IDC grading.

Indexed as

Breast NeoplasmsBreastCell NucleusEosine Yellowish-(YS)FemaleHematoxylinHumansImage Processing, Computer-AssistedEosine Yellowish-(YS)Hematoxylinattention mechanismbreast cancer gradingconvolutional neural networkhistopathological imagenuclei segmentation

Identifiers

PMID35684680
PMCPMC9185232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.